Ultrasound features as predictive markers of BRAFV600E mutation in thyroid cancer: a systematic review and meta-analysis

被引:0
作者
Liu, Rongwei [1 ,2 ]
Li, Haiyuan [1 ]
Bai, Xiumei [1 ]
Yang, Hong [1 ]
He, Yun [1 ]
机构
[1] Guangxi Med Univ, Affiliated Hosp 1, Dept Med Ultrasound, 6 Shuangyong Rd, Nanning 530021, Peoples R China
[2] Gannan Med Univ, Affiliated Hosp 1, Dept Med Ultrasound, Ganzhou, Peoples R China
关键词
Thyroid cancer; ultrasound features; BRAFV600E; meta-analysis; BRAF MUTATION; CARCINOMA;
D O I
10.21037/gs-24-134
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background: Conflicting evidence exists on the predictive value of ultrasound characteristics for BRAFV600E gene expression in thyroid cancer. This study aimed to determine the predictive value of ultrasound features for BRAFV600E gene expression status in thyroid cancer. Methods: A systematic review of studies published before December 31, 2023, was conducted in the PubMed, Web of Science, and Cochrane Library databases. Studies evaluating the ultrasonographic features for predicting BRAFV600E gene mutations in thyroid cancer were included. The relevant data were extracted, and the quality of eligible studies was independently assessed by two reviewers. Statistical analysis was performed using RevMan 5.4 and Stata 12.0 software. Results: The meta-analysis included 13 studies involving a total of 2,250 thyroid cancer patients. Ultrasound features significantly associated with BRAFV600E gene expression status in thyroid cancer (P<0.05) comprised hypoechogenicity, absence of halo, irregular borders, and vertical orientation. Contrastingly, no significant differences were observed in solid composition, irregular shape, and microcalcifications (P>0.05). Among the seven ultrasound features, the ones with superior combined sensitivity for nodules were hypoechogenicity, solid composition, absence of halo, and irregular borders, with sensitivities of 0.93 [95% confidence interval (CI): 0.87-0.96], 0.93 (95% CI: 0.86-0.97), 0.83 (95% CI: 0.72-0.91), and 0.74 (95% CI: 0.64-0.83), respectively. Finally, the areas under the summary receiver operating characteristic (SROC) curve with the highest diagnostic performance were the absence of halo and hypoechogenicity, with area under the curve (AUC) of 0.84 (95% CI: 0.80-0.87) and 0.81 (95% CI: 0.77- 0.84), respectively. Conclusions: The expression status of the BRAFV600E gene in thyroid cancer correlates with nodules exhibiting hypoechogenicity, absence of halo, irregular borders, and taller-than-wide shape. Notably, the absence of a halo and hypoechogenicity were identified as the most predictive ultrasonic features. However, due to the limited sample size, there may be bias in the meta-analysis results, and more extensive research is necessary.
引用
收藏
页码:1243 / 1253
页数:14
相关论文
共 50 条
  • [31] Association Between Preoperative US, Elastography Features and Prognostic Factors of Papillary Thyroid Cancer With BRAFV600E Mutation
    Xu, Jun-Mei
    Chen, Yong-Jun
    Dang, Yuan-Yuan
    Chen, Man
    FRONTIERS IN ENDOCRINOLOGY, 2020, 10
  • [32] Incidence and Predictive Factors of Inadequate Fine-Needle Aspirates for BRAFV600E Mutation Analysis in Thyroid Nodules
    Lee, Kwang Hwi
    Kim, Hyun Su
    Han, Boo-Kyung
    Ko, Eun Young
    Ki, Chang-Seok
    Shin, Jung Hee
    AMERICAN JOURNAL OF ROENTGENOLOGY, 2014, 202 (02) : 391 - 396
  • [33] Meta-Analyses of Association Between BRAFV600E Mutation and Clinicopathological Features of Papillary Thyroid Carcinoma
    Zhang, Qing
    Liu, Shao-zheng
    Zhang, Qing
    Guan, Yan-xing
    Chen, Qing-jie
    Zhu, Qin-yao
    CELLULAR PHYSIOLOGY AND BIOCHEMISTRY, 2016, 38 (02) : 763 - 776
  • [34] Retrospective study of BRAFV600E mutation and CT features of papillary thyroid carcinoma
    Hong, Xiaoquan
    Li, Juxiang
    Duan, Shaoyin
    You, Youkuang
    PEERJ, 2024, 12
  • [35] The BRAFV600E mutation analysis and risk stratification in papillary thyroid carcinoma
    Scheffel, Rafael Selbach
    de Cristo, Ana Patricia
    Romitti, Mirian
    Ferreira Vargas, Carla Vaz
    Ceolin, Lucien
    Zanella, Andre B.
    Dora, Jose Miguel
    Maia, Ana Luiza
    ARCHIVES OF ENDOCRINOLOGY METABOLISM, 2020, 64 (06): : 751 - 757
  • [36] BRAFV600E Is Correlated with Recurrence of Papillary Thyroid Microcarcinoma: A Systematic Review, Multi-Institutional Primary Data Analysis, and Meta-Analysis
    Chen, Yufei
    Sadow, Peter M.
    Suh, Hyunsuk
    Lee, Kyu Eun
    Choi, June Young
    Suh, Yong Joon
    Wang, Tracy S.
    Lubitz, Carrie C.
    THYROID, 2016, 26 (02) : 248 - 255
  • [37] AI-BRAFV600E: A deep convolutional neural network for BRAFV600E mutation status prediction of thyroid nodules using ultrasound images
    Xi, Chuang
    Du, Ruiqi
    Wang, Ren
    Wang, Yang
    Hou, Liying
    Luan, Mengqi
    Zheng, Xuan
    Huang, Hongyan
    Liang, Zhixin
    Ding, Xuehai
    Luo, Quanyong
    Shen, Chentian
    VIEW, 2023, 4 (02)
  • [38] Effects of Coexistent BRAFV600E and TERT Promoter Mutations on Poor Clinical Outcomes in Papillary Thyroid Cancer: A Meta-Analysis
    Moon, Shinje
    Song, Young Shin
    Kim, Ye An
    Lim, Jung Ah
    Cho, Sun Wook
    Moon, Jae Hoon
    Hahn, Seokyung
    Park, Do Joon
    Park, Young Joo
    THYROID, 2017, 27 (05) : 651 - 660
  • [39] DUAL PRIMING OLIGONUCLEOTIDE-BASED MULTIPLEX PCR ANALYSIS FOR DETECTION OF BRAFV600E MUTATION IN FNAB SAMPLES OF THYROID NODULES IN BRAFV600E MUTATION-PREVALENT AREA
    Kwak, Jin Young
    Kim, Eun-Kyung
    Kim, Jong-Kee
    Han, Jeong-Hyun
    Hong, Soon Won
    Park, Tae Sung
    Choi, Jong Rak
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2010, 32 (04): : 490 - 498
  • [40] Associations between BRAFV600E and prognostic factors and poor outcomes in papillary thyroid carcinoma: a meta-analysis
    Chunping Liu
    Tianwen Chen
    Zeming Liu
    World Journal of Surgical Oncology, 14